This site provides information on the conduct of human subjects research and FDA-regulated clinical trials during the COVID-19 pandemic. Operational changes to the UW-Madison and UW Health clinical research infrastructure programs (e.g., Office of Clinical Trials, Pharmaceutical Research Center, Clinical Research Unit) will be regularly updated. Additionally, this site will share best practices and resources across the many UW-Madison schools, colleges, and departments that conduct human subjects research.
Check the below sites for other campus updates.
The Clinical Research Unit (CRU) has released updated guidance to keep study teams and participants informed.August 17, 2020
Betsy Nugent, CCRO, has provided a follow-up letter to further inform stakeholders about current clinical research operations. Please share the updated letter with research sponsors and include within regulatory binders as necessary. COVID19 Letter …August 4, 2020
Achieving Data Quality and Integrity in Clinical Trials Involving High Consequence PathogensJune 24, 2020
Channel 15 | NBC MadisonJune 24, 2020
Milwaukee Journal SentinelJune 24, 2020
- Read more